CDISC and statistical analysis for Phase I Study
The Agilis team is happy to have successfully completed another demanding biostatistics project for a Phase I study of an innovative inflammatory eye disorder treatment for a specialised CRO and an innovative biotech company. Our work at this last stage of the project was to prepare and validate the CDISC SDTM and ADAM packages for […]
